Feasibility Study of Tumor Blood Flow Measurement by Detection of Positron Activation Post Proton Therapy (DS01)

Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET

NCT01065818 ·Status: TERMINATED ·Phase: NA

Fluorine F18-EF5 and Fludeoxyglucose F18 Positron Emission Tomography in Assessing Hypoxia and Glycolysis in Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer

NCT01017133 ·Status: COMPLETED ·Phase: PHASE1

Improving Clinical PET/CT Image Quality in Retrospectively Reconstructed Breath-Hold Images

NCT01109953 ·Status: TERMINATED

Phase 2 Study Comparing 99mTc-EC-DG SPECT/CT With 18F FDG PET/CT in Patients With Non-small Cell Lung Cancer (NSCLC)

NCT00865319 ·Status: COMPLETED ·Phase: PHASE2

PET-DECT for Staging and Imaged Based Radiotherapy Planning in Lung Cancer

NCT03146117 ·Status: TERMINATED

Early Response Evaluation of Proton Therapy by PET-imaging in Squamous Cell Carcinoma Located in the Head and Neck

NCT03513042 ·Status: TERMINATED

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer Patients

NCT06082492 ·Status: RECRUITING ·Phase: NA

Prognostic Value of Tumor Hypoxia, as Measured by 18F-FMISO Breath Hold PET/CT, in Non-Small-Cell-Lung Cancer (NSCLC) Patients

NCT02016872 ·Status: COMPLETED ·Phase: NA

Positron Emission Tomography for Detecting Non-small Cell Lung Cancer

NCT00004138 ·Status: COMPLETED ·Phase: NA

A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

NCT02130492 ·Status: SUSPENDED ·Phase: PHASE1/PHASE2

FDG PET and DCE-MRI in Predicting Response to Treatment in Patients With Breast Cancer

NCT01931709 ·Status: TERMINATED ·Phase: NA

Assessment of 4D 18F-FDG PET-CT in Radiotherapy for Non Small Cell Lung Cancers

NCT01421953 ·Status: COMPLETED ·Phase: NA

Radiotherapy Planning Based on Positron Emission Tomography With Fluoro-deoxyglucose For Advanced NSCLC

NCT00697333 ·Status: UNKNOWN ·Phase: PHASE2

Biomarker Correlates of Hypoxia in Metastatic Melanoma

NCT02061007 ·Status: WITHDRAWN ·Phase: PHASE2

F-18 Fluorothymidine PET Imaging for Early Evaluation of Response to Therapy in Head & Neck Cancer Patients

NCT00721799 ·Status: COMPLETED ·Phase: PHASE2

[18F]F-AraG/Total Body PET Imaging and Healthy Subjects and Lung Cancer Patients

NCT04678440 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Serial [18F]Fluorodeoxyglucose ([18F]FDG )PET/CT as a Biomarker of Therapeutic Response in Anti-PD1/PDL1 Therapy

NCT02608528 ·Status: TERMINATED

Prognostic Utility of the Imaging and Biological Signatures in Nasopharyngeal Carcinoma

NCT04417985 ·Status: COMPLETED ·Phase: NA

FLT-PET/DW-MRI for Detection of Brain Metastases and Early Therapy Evaluation in Patients With Small Cell Lung Cancer

NCT02995902 ·Status: COMPLETED ·Phase: NA

Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

NCT06199713 ·Status: RECRUITING

FLT-PET for Early Detection of Relapse in Patients With Irradiated Lung Cancer

NCT02995889 ·Status: COMPLETED ·Phase: NA

Fludeoxyglucose F18 Positron Emission Tomography Imaging In Assessing Patients Before and After Treatment for Locally Advanced Non-Small Cell Lung Cancer

NCT00083083 ·Status: UNKNOWN ·Phase: PHASE2

Predictive Value of FDG-PET-CT Scans for Patients With Lung Cancer Receiving Concurrent Chemo-Radiation

NCT00522639 ·Status: TERMINATED ·Phase: PHASE3

Intraoperative Imaging of a PET Positive Lymph Node(s) Using 18FDG and a Dual-Mode, Hand-Held Intraoperative Imager

NCT03561324 ·Status: WITHDRAWN ·Phase: NA

Positron Emission Tomography Using Fluorine F 18 EF5 to Find Oxygen in Tumor Cells of Patients Who Are Undergoing Surgery or Biopsy for Newly Diagnosed Brain Tumors

NCT00110032 ·Status: TERMINATED ·Phase: PHASE1